W.G. Shaheen & Associates Dba Whitney & CO Charles River Laboratories International, Inc. Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 07, 2019	SELL	$105.09 - $137.23 $15,763 - $20,584	-150 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $16,816 - $20,181	150 New	150 $20,000

Others Institutions Holding CRL

# of Institutions

693

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.14 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$955 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$702 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$400 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$364 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account